510(k) Report

510(k) · Cleared

Recalled · Class I · 2021

Modification to: Monojet Prefill 0.9% Sodium Chloride Flush Syringe, Monojet Prefill Heprin Lock Flush Syringe

K032438510(k) TraditionalCleared Jun 30, 2004328-day reviewClass II21 CFR 880.5200Recalls 26 (4 Class I)

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Tyco Healthcare · NGT Saline, Vascular Access Flush

Cleared on Jun 30, 2004 as substantially equivalent to K011283 (The Kendall Company, 2001) and 1 other predicate after a 328-day review. Its family tree reaches back 2 generations to 2000. 1 of the 6 devices in its family, counting itself, has a Class I recall. 2 later devices descend from it. It has been recalled 26 times, including 4 Class I recalls.

Decided
Jun 30, 2004
Review
328 days
Class
Class II
Product code
NGT
Recalls
26 (4 Class I)
Predicates
2

Its longest line of descent runs back 2 generations to K003245 (2000). 3 ancestors in all. 2 later devices descend from it, 2 citing it directly. 1 of the 6 devices in this family, counting this one, has a Class I recall.

Other ancestors, by year clearedDescendants, by year cleared 2001: 1 other ancestor2006: 1 descendant cleared2010: 1 descendant clearedK003245 · Heparin Lock Flush Syring 10 Usp Units/ML, Heparin Lock Flush Syringe, 100 Usp Units/ML · Baxter Healthcare Corp · 2000 · recalledK013556 · Monoject Prefill Heparin Lock Flush Syringe · Tyco Healthcare · 2001200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 2 descendants K013556 · Monoject Prefill Heparin Lock Flush Syringe · Tyco Healthcare · 2001K003245 · Heparin Lock Flush Syring 10 Usp Units/ML, Heparin Lock Flush Syringe, 100 Usp Units/ML · Baxter Healthcare Corp · 2000 · recalled0
  1. Root · 2 generations backK003245 Heparin Lock Flush Syring 10 Usp Units/ML, Heparin Lock Flush…Baxter Healthcare Corp · 2000 · Recalled
  2. 1 generation backK013556 Monoject Prefill Heparin Lock Flush SyringeTyco Healthcare · 2001
  3. This deviceK032438 Modification to: Monojet Prefill 0.9% Sodium Chloride Flush Syringe…Tyco Healthcare · 2004
  4. Descendant · cites it directly · 0 of its ownK090882 Flush Syringe Filled with 0.9% Sodium ChlorideHospira, Inc. · 2010 · Recalled
  5. Descendant · cites it directly · 0 of its ownK060339 Kendall Monoject Pre-Fill Advanced 0.9%Sodium Chloride Flush…Tyco Healthcare/Kendall · 2006 · Recalled

Most influential descendants

Showing 2 of 2 · See all
  • K090882Flush Syringe Filled with 0.9% Sodium ChlorideHospira, Inc. · 2010 · cites it directly0descendants
  • K060339Kendall Monoject Pre-Fill Advanced 0.9%Sodium Chloride Flush Syringes for Sterile DeliveryTyco Healthcare/Kendall · 2006 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K003245Heparin Lock Flush Syring 10 Usp Units/ML, Heparin Lock Flush Syringe, 100 Usp…Baxter Healthcare Corp20002
−1K013556Monoject Prefill Heparin Lock Flush SyringeTyco Healthcare2001—
0 (this device)K032438Modification to: Monojet Prefill 0.9% Sodium Chloride Flush Syringe, Monojet…Tyco Healthcare2004—
+1K090882Flush Syringe Filled with 0.9% Sodium ChlorideHospira, Inc.20103
+1K060339Kendall Monoject Pre-Fill Advanced 0.9%Sodium Chloride Flush Syringes for…Tyco Healthcare/Kendall200611

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200110

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200610
201010
FIG. 1 — Lineage of K032438, 2000–2010Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NGT device

  1. #1 K250884 0.9 % Sodium Chloride Injection, USP, BD…score 11.6 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K011283Monoject Prefill 0.9% Sodium Chloride Flush Syringe
Summary page 1
…valent in intended use, function and composition to the currently marketed Monoject PreFill Sodium Chloride and Heparin Lock Flush Syringes, 510(k) numbers K011283 and K013556. 4. Device Description The proposed device is a sterile, single use, standard piston syringe of va…
The Kendall Company2001—
*K013556Monoject Prefill Heparin Lock Flush Syringe
Summary page 1
…tended use, function and composition to the currently marketed Monoject PreFill Sodium Chloride and Heparin Lock Flush Syringes, 510(k) numbers K011283 and K013556. 4. Device Description The proposed device is a sterile, single use, standard piston syringe of various sizes…
Tyco Healthcare2001—

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K090882Flush Syringe Filled with 0.9% Sodium ChlorideHospira, Inc.20100
K060339Kendall Monoject Pre-Fill Advanced 0.9%Sodium Chloride Flush Syringes for Sterile DeliveryTyco Healthcare/Kendall20060

Has anything in its family been recalled? (1 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Aug 19, 2021Class IZ-0119-2022Device DesignMonoject 0.9% Sodium Chloride Flush Syringe Manufactured by Cardinal Health and placed into kits. Potential for the plunger to draw back after air has been expelled and reintroduce air back into the syringe.
Aug 4, 2021Class IZ-2284-2021Device DesignPotential for the plunger to draw back after the air has been expelled and reintroduce air back into the syringe.
Aug 4, 2021Class IZ-2286-2021Device DesignPotential for the plunger to draw back after the air has been expelled and reintroduce air back into the syringe.
Aug 4, 2021Class IZ-2285-2021Device DesignPotential for the plunger to draw back after the air has been expelled and reintroduce air back into the syringe.
Aug 16, 2013Class IIZ-2178-2013Process controlMonoject prefill flush syringes may contain non-sterile water and labeled as saline or heparin
Aug 16, 2013Class IIZ-2185-2013Process controlMonoject prefill flush syringes may contain non-sterile water and labeled as saline or heparin
Aug 16, 2013Class IIZ-2184-2013Process controlMonoject prefill flush syringes may contain non-sterile water and labeled as saline or heparin
Aug 16, 2013Class IIZ-2183-2013Process controlMonoject prefill flush syringes may contain non-sterile water and labeled as saline or heparin
Aug 16, 2013Class IIZ-2182-2013Process controlMonoject prefill flush syringes may contain non-sterile water and labeled as saline or heparin
Aug 16, 2013Class IIZ-2186-2013Process controlMonoject prefill flush syringes may contain non-sterile water and labeled as saline or heparin
Aug 16, 2013Class IIZ-2180-2013Process controlMonoject prefill flush syringes may contain non-sterile water and labeled as saline or heparin
Aug 16, 2013Class IIZ-2179-2013Process controlMonoject prefill flush syringes may contain non-sterile water and labeled as saline or heparin
Aug 16, 2013Class IIZ-2181-2013Process controlMonoject prefill flush syringes may contain non-sterile water and labeled as saline or heparin
Nov 15, 2010Not classifiedZ-0564-2011Material/Component ContaminationThe heparin sodium USP used to manufacture was produced with crude heparin containing Over-Sulfated Chondroitin Sulfate.
Nov 15, 2010Not classifiedZ-0566-2011Material/Component ContaminationThe heparin sodium USP used to manufacture was produced with crude heparin containing Over-Sulfated Chondroitin Sulfate.
Nov 15, 2010Not classifiedZ-0567-2011Material/Component ContaminationThe heparin sodium USP used to manufacture was produced with crude heparin containing Over-Sulfated Chondroitin Sulfate.
Nov 15, 2010Not classifiedZ-0568-2011Material/Component ContaminationThe heparin sodium USP used to manufacture was produced with crude heparin containing Over-Sulfated Chondroitin Sulfate.
Nov 15, 2010Not classifiedZ-0565-2011Material/Component ContaminationThe heparin sodium USP used to manufacture was produced with crude heparin containing Over-Sulfated Chondroitin Sulfate.
Nov 15, 2010Not classifiedZ-0569-2011Material/Component ContaminationThe heparin sodium USP used to manufacture was produced with crude heparin containing Over-Sulfated Chondroitin Sulfate.
Mar 28, 2008Not classifiedZ-1595-2008Material/Component ContaminationScientific Protein Laboratories (SPL), disclosed that two lots of Heparin Sodium, USP Active Pharmaceutical Ingredient has a heparin-like contaminant
Mar 28, 2008Not classifiedZ-1602-2008Material/Component ContaminationScientific Protein Laboratories (SPL), disclosed that two lots of Heparin Sodium, USP Active Pharmaceutical Ingredient has a heparin-like contaminant
Mar 28, 2008Not classifiedZ-1600-2008Material/Component ContaminationScientific Protein Laboratories (SPL), disclosed that two lots of Heparin Sodium, USP Active Pharmaceutical Ingredient has a heparin-like contaminant
Mar 28, 2008Not classifiedZ-1598-2008Material/Component ContaminationScientific Protein Laboratories (SPL), disclosed that two lots of Heparin Sodium, USP Active Pharmaceutical Ingredient has a heparin-like contaminant
Mar 28, 2008Not classifiedZ-1597-2008Material/Component ContaminationScientific Protein Laboratories (SPL), disclosed that two lots of Heparin Sodium, USP Active Pharmaceutical Ingredient has a heparin-like contaminant Tyco Healthcare, Mansfield, MA 02048
Mar 28, 2008Not classifiedZ-1599-2008Material/Component ContaminationScientific Protein Laboratories (SPL), disclosed that two lots of Heparin Sodium, USP Active Pharmaceutical Ingredient has a heparin-like contaminant
Mar 28, 2008Not classifiedZ-1596-2008Material/Component ContaminationScientific Protein Laboratories (SPL), disclosed that two lots of Heparin Sodium, USP Active Pharmaceutical Ingredient has a heparin-like contaminant

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 4 years and passes through 2 companies; a new generation was cleared every 2.5 years on median.
  • 1 of the 3 ancestors has a recall of any class.
  • Of its descendants, K090882 (Hospira, Inc., 2010) has gone furthest, with 0 descendants of its own.

How does its category compare?

All NGT devices

NGT Saline, Vascular Access Flush: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · NGT

1in 2025

2008: 12009: 12010: 22011: 32012: 42013: 12014: 32015: 12016: 12017: 22018: 12019: 22020: 22022: 32023: 62024: 12025: 1
2007high 6 (2023) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NGT

142in 2023

2011: 219 days median2012: 106 days median2014: 87 days median2022: 151 days median2023: 142 days median
2007high 219 (2011) · low 87 (2014)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NGT

1in 2025

2007: 22009: 12010: 72011: 12012: 12013: 1, 1 Class I2016: 1, 1 Class I2019: 22021: 1, 1 Class I2022: 12023: 3, 2 Class I2025: 12026 (partial year): 1, 1 Class I
2007high 7 (2010) · low 0 (2008)2026

Class I (6 since 2007) Class II/III not classified

Adverse event reports per year · NGT

212in 2025

2007: 312008: 642009: 182010: 232011: 202012: 52013: 252014: 252015: 142016: 822017: 562018: 2702019: 3402020: 3222021: 5662022: 2822023: 3132024: 3322025: 212
2007high 566 (2021) · low 5 (2012)2025

MAUDE reports naming product code NGT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—231
20081—064
20091—118
20102—723
20113219120
2012410615
20131—1 (1)25
2014387025
20151—014
20161—1 (1)82
20172—056
20181—0270
20192—2340
20202—0322
20210—1 (1)566
202231511282
202361423 (2)313
20241—0332
20251—1212
20260—1 (1)—

What is it indicated for?

The 0.9% Sodium Chloride Flush Syringe is indicated for use in flushing compatible intravenous tubing systems and indwelling intravascular access devices.

The Heparin Lock Flush Syringe, 10 and 100 units/ml is intended for use in flushing compatible intravenous administration sets and indwelling intravenous access devices.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K032438: Modification to: Monojet Prefill 0.9% Sodium Chloride Flush Syringe, Monojet Prefill Heprin Lock Flush Syringe.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K032438

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026